NRobotics Co

NRobotics Co CapEx/OCF

The CapEx to Operating Cash Flow Ratio of NRobotics Co (138360.KQ) as of Nov 12, 2026 is 2.42 %. In the previous year, CapEx to Operating Cash Flow Ratio was -13.54 % — a change of -117.84% (higher).

CapEx/OCF

2.42 %

YoY

-117.84%

Last updated:

CapEx to Operating Cash Flow Ratio of NRobotics Co is 2025 2.42 % . CapEx to Operating Cash Flow Ratio of NRobotics Co was 2024 -13.54 % . It decreases by -117.84% higher compared to the previous year.

The NRobotics Co CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
-72.97 KRW
Jan 1, 2019
6.03 KRW
Jan 1, 2020
-30.05 KRW
Jan 1, 2021
-11.02 KRW
Jan 1, 2022
-1,969.41 KRW
Jan 1, 2023
-453.57 KRW
Jan 1, 2024
-13.54 KRW
Jan 1, 2025
2.42 KRW
The NRobotics Co CapEx/OCF history
YEARCapEx/OCFYoY
2.42 %-117.84%
-13.54 %-97.01%
-453.57 %-76.97%
-1,969.41 %+17,772.72%
-11.02 %-63.33%
-30.05 %-598.26%
6.03 %-108.26%
-72.97 %-46.61%
-136.69 %-168.37%
199.92 %-63.29%
544.54 %+200.83%
181.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NRobotics Co Stock analysis

What does NRobotics Co do? Hyupjin Co., Ltd. generates revenue through the manufacture and sale of cosmetic ingredients, including bioconversion technology products, encapsulated products, natural extracts, and synthetic products. Key products such as Aquatouch L, Silkytouch L, Phytoact Reliefer, PhytoAct CosyPlex, Actosome InoCeramide E06, Actosome Retinol850, Actosome Retinal Palmitate, Actostem GinElixir, and Actosome Deage are sold to clients in the cosmetics industry. The company provides electronic materials as part of its product portfolio, targeting manufacturers seeking high-quality cosmetic ingredients and materials for their formulations. Hyupjin Co., Ltd. focuses on delivering specialized cosmetic ingredients through its range of products, with each product composed of specific ingredients like glycerin, dimethicone, water, lecithin, and various plant extracts. The company’s offerings cater to the needs of cosmetic manufacturers who require advanced formulations for skincare and beauty products. Its product lineup includes both natural and synthetic options, supporting diverse applications in the beauty sector. The company’s product portfolio includes Aquatouch L, Silkytouch L, and multiple Actosome series products, all designed to meet the demands of cosmetic manufacturers. These products are formulated with ingredients such as phaseolus radiates seed extract, avena sativa meal extract, and ethyhexylglycerin, among others. Hyupjin Co., Ltd. serves the cosmetics industry by providing ingredients that enhance product performance and consumer appeal, leveraging its bioconversion technology and natural extract expertise. NRobotics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NRobotics Co stock

CapEx to Operating Cash Flow Ratio of NRobotics Co is 2.42 % in 2025.

CapEx to Operating Cash Flow Ratio of NRobotics Co changed from -13.54 % to 2.42 %, representing a -117.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio NRobotics Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's NRobotics Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — NRobotics Co

All Key Metrics — NRobotics Co